NCT03486873 2026-03-16
MK-3475-587
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
16 trialsNCT03067181 2026-02-27
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Children's Oncology Group
Phase 3 Recruiting
NCT06585410 2026-02-25
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT06513962 2026-02-24
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
Phase 3 Recruiting
NCT06855277 2026-02-24
AcTFirst
Novartis
Phase 3 Recruiting
NCT04307277 2026-02-11
CHIC-STS01
Institut Claudius Regaud
Phase 3 Recruiting
NCT06563388 2026-02-04
ID-COMET
Roswell Park Cancer Institute
Phase 3 Recruiting
NCT07186192 2026-01-28
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
City of Hope Medical Center
Phase 3 Recruiting
NCT05006482 2026-01-13
GEM-S
University of Rochester
Phase 3 Recruiting
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT05865743 2025-03-05
PERSuaDER
Radboud University Medical Center
Phase 3 Recruiting
NCT06857773 2025-03-04
PUMP-IT RCT
The Netherlands Cancer Institute
Phase 3 Recruiting
NCT06496581 2024-12-20
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
UNICANCER
Phase 3 Recruiting
NCT06646809 2024-10-17
RISIS-CR
National University Hospital, Singapore
Phase 3 Recruiting
NCT06391892 2024-04-30
LIQUIPANC
Elisabethinen Hospital
Phase 3 Recruiting
NCT04646564 2022-01-11
Radiotherapy for Extracranial Oligometastatic Breast Cancer
ChineseAMS
Phase 3 Recruiting